Kissei Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 12, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	192,752	164,586	156,266	121,792	117,826	112,984
Market Cap Growth	16.66%	5.32%	28.31%	3.36%	4.29%	-13.03%
Enterprise Value	148,613	122,521	115,492	77,037	78,311	68,996
Last Close Price	4650.00	3793.10	3395.74	2477.94	2323.47	2179.00
PE Ratio	13.78	13.76	14.00	11.57	9.12	21.38
Forward PE	15.45	17.88	14.26	10.90	36.67	28.42
PS Ratio	2.02	1.86	2.07	1.81	1.80	1.64
PB Ratio	0.89	0.78	0.71	0.63	0.58	0.51
P/TBV Ratio	0.90	0.80	0.72	0.63	0.59	0.52
P/FCF Ratio	-	81.72	-	-	2677.87	-
P/OCF Ratio	-	25.24	-	-	76.86	-
EV/Sales Ratio	1.56	1.39	1.53	1.14	1.20	1.00
EV/EBITDA Ratio	54.24	11.79	13.96	25.97	33.64	14.83
EV/EBIT Ratio	-	21.22	28.75	-	-	45.81
EV/FCF Ratio	-	60.83	-	-	1779.80	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.46	0.12	0.16	0.50	0.70	0.37
Debt / FCF Ratio	-	0.64	-	-	37.27	-
Asset Turnover	0.38	0.35	0.31	0.29	0.26	0.28
Inventory Turnover	1.85	1.73	1.56	1.68	1.75	2.17
Quick Ratio	3.28	4.68	4.17	4.79	4.01	3.70
Current Ratio	4.50	6.45	5.92	6.73	5.30	5.10
Return on Equity (ROE)	6.66%	5.55%	5.43%	5.36%	6.17%	2.60%
Return on Assets (ROA)	-0.53%	1.43%	1.04%	-0.31%	-0.35%	0.38%
Return on Invested Capital (ROIC)	-1.07%	2.61%	1.94%	-0.60%	-0.68%	0.69%
Return on Capital Employed (ROCE)	-0.90%	2.50%	1.70%	-0.60%	-0.60%	0.60%
Earnings Yield	7.33%	7.27%	7.14%	8.64%	10.97%	4.68%
FCF Yield	-	1.22%	-1.84%	-7.21%	0.04%	-3.07%
Dividend Yield	2.59%	2.64%	2.42%	3.23%	2.41%	2.48%
Payout Ratio	-	31.78%	33.35%	29.78%	19.63%	46.83%
Buyback Yield / Dilution	4.74%	3.62%	1.86%	-	1.18%	0.11%
Total Shareholder Return	7.32%	6.25%	4.27%	3.23%	3.59%	2.58%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.